Opportunity ID: 210733

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-AI-12-048
Funding Opportunity Title: Immune Mechanisms of Virus Control (U19)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.855 — Allergy, Immunology and Transplantation Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Dec 12, 2012
Last Updated Date:
Original Closing Date for Applications: Apr 16, 2013
Current Closing Date for Applications: Apr 16, 2013
Archive Date: May 17, 2013
Estimated Total Program Funding: $15,000,000
Award Ceiling: $1,500,000
Award Floor:

Eligibility

Eligible Applicants: Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
State governments
Small businesses
For profit organizations other than small businesses
City or township governments
Independent school districts
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Native American tribal organizations (other than Federally recognized tribal governments)
County governments
Native American tribal governments (Federally recognized)
Special district governments
Public and State controlled institutions of higher education
Public housing authorities/Indian housing authorities
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name: National Institutes of Health
Description: The National Institute of Allergy and Infectious Diseases (NIAID) invites multi-project applications to be part of a network of synergistic research teams focused on the immunological parameters of virus infection and vaccination that are important for understanding the key molecular and cellular immune mechanisms involved in the natural control of infection, the induction of protective immunity by vaccination, or the immune-mediated processes that cause pathology after virus infection or vaccination. Studies involving multiple viruses are encouraged to foster discovery of novel immune mechanisms and generalizable principles of anti-viral immunity. The viruses of interest to the Immune Mechanisms of Virus Control (IMVC) program are listed as part of the NIAID Emerging and Re-emerging Infectious Diseases (http://www.niaid.nih.gov/topics/emerging/Pages/list.aspx). The ultimate goal of this program is to discover and define novel basic immune mechanisms for controlling virus infections that will lead to new potential targets for developing future vaccines and therapeutics.
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-12-048.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages

2025-07-11T09:42:15-05:00

Share This Post, Choose Your Platform!

About the Author: